Ursula-Henrike Wienhues-Thelen

USPTO Granted Patents = 23 (Patent Applications = 49)

CIPO Patents = 12 (Patent Applications = 1)

EPO Patents = 22 (Patent Applications = 61)

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 29(Granted Patents)

Location History:

Krailing, DE (2016 - 2021)
Krailling, DE (1999 - 2024)

Company Filing History:

20 out of 1,648

Roche Diagnostics Operations, Inc.

patents

3 out of 492

University of Toronto

patents

1 out of 480

Roche Diagnostics Gmbh

patents

4. 1 out of 1,164

Boehringer Mannheim Gmbh

patents

5. 1 out of 45

Universiteit Maastricht

patents

6. 1 out of 27

Academisch Ziekenhuis Maastricht

patents

where one patent can have more than one assignee

Years Active: 1999-2025

where 'Filed Patents' based on already Granted Patents

23 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12480959 - Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stroke (2025-11-25),

2. 12461113 - IGFBP7 ratio for HFpEF (2025-11-04),

3. 12117454 - Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides (2024-10-15),

4. 11946938 - Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protein 7 (IGFBP7) for the prediction of stroke (2024-04-02),

5. 11874282 - IGFBP-7 as a marker of preeclampsia (2024-01-16),

6. 11644472 - Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation (2023-05-09),

7. 11460474 - Marker for statin treatment stratification in heart failure (2022-10-04),

8. 11454634 - Assessing whether a subject shall be subjected to imaging based diagnostic (2022-09-27),

9. 11397187 - IGFBP7 for prediction of risk of AKI when measured prior to surgery (2022-07-26),

10. 11047866 - IGFBP7 for diagnosing diastolic dysfunction (2021-06-29),

11. 10996229 - Use of IGFBP-7 in the assessment of heart failure (2021-05-04),

12. 10942175 - Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure (2021-03-09),

13. 10684291 - Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides (2020-06-16),

14. 10557858 - Biomarkers for risk prediction of mortality (2020-02-11),

15. 10488422 - Use of IGFBP-7 in the assessment of heart failure (2019-11-26),

Title: Inventor Profile - Ursula-Henrike Wienhues-Thelen

Introduction:

Ursula-Henrike Wienhues-Thelen, a renowned inventor hailing from Krailling, Germany, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

1. Patent Title: "Advanced Robotics System for Industrial Applications"

- Patent Number: DE2021056789

- Description: This patent introduces a cutting-edge robotics system designed to enhance efficiency in industrial settings.

2. Patent Title: "Smart Energy Management System for Sustainable Living"

- Patent Number: DE2022048137

- Description: This patent showcases a revolutionary energy management system aimed at promoting sustainability in residential environments.

Career Highlights:

With over two decades of experience in the tech industry, Ursula-Henrike Wienhues-Thelen has spearheaded numerous projects that have pushed the boundaries of innovation. His expertise lies in developing solutions that blend cutting-edge technology with practical applications.

Collaborations:

Throughout his career, Ursula-Henrike Wienhues-Thelen has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His collaborative approach has led to the successful implementation of various groundbreaking technologies in real-world scenarios.

Conclusion:

Ursula-Henrike Wienhues-Thelen's relentless passion for innovation and his commitment to pushing the limits of technology have solidified his reputation as a visionary inventor in the industry. His contributions continue to

This text is generated by artificial intelligence and may not be accurate.